Literature DB >> 8593483

Hinokitiol induces differentiation of teratocarcinoma F9 cells.

N Muto1, A Dota, T Tanaka, N Itoh, M Okabe, A Inada, T Nakanishi, K Tanaka.   

Abstract

Hinokitiol, a constituent of the wood of Chamaecyparis taiwanensis, was found to induce differentiation of teratocarcinoma F9 cells. When examined by the agar-overlay method, in which expression of plasminogen activator as a differentiation marker protein was detected, this compound exhibited a dose- and time-dependent induction. Induction of differentiation by hinokitiol occurred irreversibly and required its addition for more than 12h. Among its structure-related compounds tested, tropolone and two colchicine-related compounds exerted potent activities comparable to that of hinokitiol. These findings indicate that free tropolone structure in the molecules plays an essential role in inducing differentiation of F9 cells. Hinokitiol showed a strong inhibitory effect of DNA synthesis in very early stages of culture, suggesting that this effect may be responsible for triggering differentiation of F9 cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593483     DOI: 10.1248/bpb.18.1576

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

1.  Induction of apoptosis by hinokitiol, a potent iron chelator, in teratocarcinoma F9 cells is mediated through the activation of caspase-3.

Authors:  Y Ido; N Muto; A Inada; J Kohroki; M Mano; T Odani; N Itoh; K Yamamoto; K Tanaka
Journal:  Cell Prolif       Date:  1999-02       Impact factor: 6.831

2.  Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor.

Authors:  Dom-Gene Tu; Yun Yu; Che-Hsin Lee; Yu-Liang Kuo; Yin-Che Lu; Chi-Wen Tu; Wen-Wei Chang
Journal:  Oncol Lett       Date:  2016-03-02       Impact factor: 2.967

3.  New therapeutic strategy of hinokitiol in haemorrhagic shock-induced liver injury.

Authors:  Wan-Jung Lu; Kuan-Hung Lin; Mei-Fang Tseng; Kuo-Ching Yuan; Hung-Chang Huang; Joen-Rong Sheu; Ray-Jade Chen
Journal:  J Cell Mol Med       Date:  2018-12-08       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.